ResoTher Pharma is extremely pleased to announce our nomination as winner of the European-wide 2019 Advance Biotech Awards, issued by German pharma conglomerate Merck AG. ResoTher Pharma was one of many European contestants for the prestigious award and was selected by an internal Merck jury of experienced industry peers as 3rd place winner in the contest. The prize of 50.000 EUR will contribute towards the further preclinical development of the company´s lead drug candidate for acute myocardial infarction. An article from industry media Labiotech announcing the contest winners can be found here.
ResoTher Pharma wins prestigious Merck Advance Biotech Grant Award
|Published on: Feb 1, 2019||